Thomas E. Shenk

This profile gathers the share dealings of Thomas E. Shenk across 5 companies, led by CV Therapeutics Inc, Cell Genesys Inc and MeiraGTx Holdings plc. Between 29 June 2007 and 20 July 2020, the trades on record add up to 17 filings.

On the market, this insider has only sold: 3 sales, €179k in total. The rest of the record consists of 8 share grants and 4 option exercises. 2020 to date brings no purchases and 3 sales.

The latest filing, published on 22 July 2020, reports an open-market sale of €87k in MeiraGTx Holdings plc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.